CBA-USA Successfully Held the Fourth Biopharmaceutical Development Workshop on February 19, 2017 in Maryland, USA

CBA-USA Successfully Held the Fourth Biopharmaceutical Development Workshop on February 19, 2017 in Maryland, USA

2016-2017 Workshop series-4

Entrepreneurs in Biopharmaceutical field

Sharing experience and advising your real start-up plan


CBA-USA successfully organized the fourth seminar of biopharmaceutical development workshop on February 19, 2017. This event is co-sponsored by Chinese Culture and Community Service Center (CCACC), Chinese Students and Scholars Association at the National Institute of Health (NIH-CSSA) and American Society for Quality-Washington DC and Maryland Metro, Section 509. Nearly 80 professionals attended the forth work shop at CCACC in Gaithersburg, Maryland.


CBA currently has over 3000 registered individual members (www.cba-USA.org).The goal of this series of CBA workshops is to provide opportunities for biomedical professionals to gain a deeper understanding of drug development and marketing approval. At the same time, the CBA workshop is a unique networking platform for local biomedical professionals. Speakers and attendees will have opportunities to discuss the current state-of-art practice, future directions, and career development in biopharmaceutical field.


The forth workshop focused on how to successfully start, run and grow your biopharmaceutical companies. We invited four entrepreneurs from biopharmaceutical industry, ranging from small start-ups to multinational biotech and contract research organization (CRO). The speakers presented their distinguished backgrounds and past achievements, as well as successful and failed stories during entrepreneurship. Further, valuable advice and guidance were shared for future entrepreneurs. Markedly, family support is critical for running a successful business.


Dr. Dazhi Lai, founder of SPEED Biosystems, started his reagent service company after being frustrated as a postdoctoral researcher in Yale University and the NIH. He mentioned that entrepreneurship not only gives him financial reward, but also promotes his spirituality. Next, Mr. Charles Li, senior director of Poochon Scientific LLC, presented their sophisticated business model of how to identify customers, expand market and practically analyze profit. The third speaker is previous CBA president Patrick Y. Lu. Currently, he is founder, president and CEO of Sirnaomics, Inc.in Rockville, Maryland and chairman of board of directors of Suzhou Sirnaomics Pharmaceuticals, Ltd. in Biobay, SIP, China. Dr. Lu showed his impressive 20 years’ drug discovery and development trip to potentially the first RNAi based therapy, which could be used for treatment of many diseases. At the same time, Dr. Lu has published many top-class research articles and applied for many patents. The last speaker Dr. Dan Zhang is chairman of board of directors of Fountain Medical Development. He also served as CBA president previously. Dr. Zhang shared his unique experience in working with both governments and venture capitals in China. His company is one of the largest CROs in China. Dr. Zhang shared his insight into current biopharmaceutical industry in China. During lunch and network time, participants had good communications with each other. At the end of the workshop, Drs. Frank Li and George Chang hosted the panel discussion and lottery.


CBA is dedicated to bridging the Chinese and US biopharmaceutical industries. We will continue to organize the bimonthly workshop. CBA will organize career development workshop and job fair in April. The 2017 CBA annual conference will be in June. We will post more information in the following month. Please stay tuned. If you have any advice for this event, please feel free to contact contact@cba-usa.org.


Displaying IMG_0339.JPG

Photo legend:

Front from left: Charles Li, Dazhi Lai, Dan Zhang, and Patrick Y. Lu

Back from left: George Chang, Kening Li, Joe Zhang, Dong Shen,  Yuling Li, Wei Sun, and Frank Li (Source: Frank Li)